FDA Approves PENTAZOCINE AND NALOXONE — Sun Pharmaceutical Industries, Inc.
Sun Pharmaceutical Industries, Inc. secured FDA approval for the generic version of PENTAZOCINE AND NALOXONE, a strategic addition anticipated to boost the company’s revenue potential and expand its footprint within the U.S. generic analgesic market.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day